SU11248, A selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

References

• Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biological properties of VEGF and its recepters. Nat Med 2003; 9:669 - 676
   PubMed Web of Science ®Google Scholar
• Morabito A, De Maio E, Di Mio M, Normanno N, Perrone F. Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions. Oncologist 2006; 11:753 - 764
   PubMed Web of Science ®Google Scholar
• Brown LF, Berse B, Jackman RW, Tognazzi K, Guiddi AJ, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995; 26:86 - 91
   PubMed Web of Science ®Google Scholar
• Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, et al. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT-1. PLOS Med 2007; 4:1101 - 1115
   Web of Science ®Google Scholar
• Gu JW, Young E, Busby B, Covington J, Tan W, Johnson JW. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis and growth of breast cancer in female mice. Cancer Biol Ther 2009; 8:514 - 521
   PubMed Web of Science ®Google Scholar
• Sirotnak FM, Otter GM, Schmid FA. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumor. Cancer Res 1993; 53:587 - 591
   PubMed Web of Science ®Google Scholar
• Maione P, Gridelli C, Troiani T, Ciardiello F. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC. Oncologist 2006; 11:274 - 284
   PubMed Web of Science ®Google Scholar
• Tan W, Bailey AP, Shparago M, Busby B, Covington J, Gu JW, et al. Chronic alcohol consumption stimulates VEGF expression, tumor angiogenesis and progression of melanoma in mice. Cancer Biol Ther 2007; 6:1211 - 1217
   PubMed Web of Science ®Google Scholar
• Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE, et al. Molecular profiling of angiogenesis markers. Am J Pathol 2002; 161:35 - 42
   PubMed Web of Science ®Google Scholar
• Gu JW, Bailey AP, Sartin A, Makey I, Brady AL. Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos. Cancer 2005; 103:422 - 431
   PubMed Web of Science ®Google Scholar
• Fife RS, Sledge GW Jr. Effects of doxycycline on in vitro growth, migration and gelatinase activity of breast carcinoma cells. J Lab Clin Med 1995; 125:407 - 411
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994; 12:441
   PubMed Web of Science ®Google Scholar
• Zuo Y, Shields SK, Chakraborty C. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem Biophys Res Commun 2006; 15:361 - 367
   Web of Science ®Google Scholar
• Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, et al. A compact VEGF signature associated with distant metastases and poor outcome. BMC Med 2009; 7:9
   PubMed Web of Science ®Google Scholar
• Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Harkonen PL. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 1999; 149:29 - 40
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, et al. Vascular endothelial growth factor is an autocrine survival factor for neuroplin-expressing breast carcinoma cells. Cancer Res 2001; 61:5736 - 5740
   PubMed Web of Science ®Google Scholar
• Buteau-Lozano H, Ancelin M, Lardeux B, Malanini J, Perrot-Applanat M. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors α and β. Cancer Res 2002; 62:4977 - 4984
   PubMed Web of Science ®Google Scholar
• Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, et al. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer 2009; 8:81
   PubMed Web of Science ®Google Scholar
• Gasparini G, Longo R, Torino F, Morabito A. Therapy of breast cancer with molecular targeting agents. Ann Oncol 2005; 16:26 - 28
   Web of Science ®Google Scholar
• Rosen LS, Louise H, Chap L. Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review. Oncologist 2010; 15:216 - 235
   PubMed Web of Science ®Google Scholar
• Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology and End Results database. Breast Cancer Res 2002; 76:27 - 36
   Web of Science ®Google Scholar
• Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor and other angiogenic factors in human breast cancer. Cancer Res 1996; 56:2013 - 2016
   PubMed Web of Science ®Google Scholar
• Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 2001; 12:129 - 135
   PubMedGoogle Scholar
• Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou ES, et al. Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 2009; 11:84
   Web of Science ®Google Scholar
• Liang Y, Brekken PA, Hyder SM. Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of antihormones. Endocr Relat Cancer 2006; 13:905 - 919
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62:7203 - 7206
   PubMed Web of Science ®Google Scholar
• Yan D, Qin N, Zhang H, Liu T, Yu M, Jiang X, et al. Expression of TNFα leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNFα. Breast Cancer Res Treat 2009; 116:91 - 102
   PubMed Web of Science ®Google Scholar
• Li N, Karin M. Is NFkappaB the sensor of oxidative stress?. FASEB J 1999; 13:1137 - 1143
   PubMed Web of Science ®Google Scholar
• Bharti A, Aggarwal BB. Nuclear factor-kappaB and cancer: its role in prevention and therapy. Biochem Pharmacol 2002; 64:883 - 888
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression Nature 2006; 441:431 - 436
   Google Scholar